Author(s):
Natural killer (NK) cells, as potent effectors of innate immunity, hold immense potential in cancer immunotherapy. This article explores the current strategies and future prospects of harnessing the power of NK cells in cancer immunotherapy. Key topics include NK cell biology, therapeutic approaches, combination strategies, challenges, and emerging technologies shaping the landscape of NK cell-based cancer treatments.
